President-elect Donald Trump on Tuesday named Rep. Tom Price (R-Ga.) as his pick for Health and Human Services secretary, a position that could offer the anti-marijuana legislator more control over medical access to the drug.
Although federal regulation of illicit drugs rests primarily with the Justice Department, the HHS secretary holds some powers that could restrict how available marijuana is in states that have legalized it for recreational or medicinal use. For instance, drug policy observers say that the agency could penalize doctors or sue sellers who work with medical marijuana in those states, since the substance remains illegal under federal law.
Price is one of the most consistently anti-marijuana members of Congress, voting against a number of marijuana proposals before the House in recent years.
“Price has a long voting record of opposing the [modest] marijuana policy reforms that have come to a vote in the House of Representatives,” said John Hudak of the Brookings Institution in an email. “Price is a physician and the medical community broadly has been conservative about the use of medical marijuana and nearly universally opposes it for recreational use.”
Price’s record includes:
- Going against a measure that would prevent the Justice Department from interfering with state recreational marijuana laws.
- Voting six times against amendments preventing the Justice Department from interfering with state medical marijuana laws.
- Voting three times against a measure that would allow Veterans Affairs doctors to recommend medical marijuana to veterans who might benefit from it.
But Price has supported a limited measure preventing the Justice Department from interfering with states that allow the medical use of cannabidiol, a non-psychoactive chemical component of marijuana that shows promise in treating some forms of epilepsy. He has also voted to ensure that federal funds aren’t used to stymie research into industrial uses of hemp.
While not particularly vocal on the subject of marijuana law, Price’s votes have earned him a “D” grade on marijuana policy from the National Organization for the Reform of Marijuana Laws and Drug Policy Action, two drug policy reform groups.
Read More at Washington Post